• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

Setting Up For The Next Bull Market

Tech Letter

Taking out long-term leases and turning around to rent short-term i.e. Airbnb style for corporate offices ended with a thud as office sharing tech company WeWork filed for bankruptcy.

The idea never made sense and felt more like a gimmick.

Surprisingly, this bankruptcy didn’t happen much earlier as the “work from home” pivot during 2020-2022 made this business model go from bad to worse.

It’s safe to say that we are far passed the peak “sharing economy” and investors are licking their wounds on this one.

WeWork filed for bankruptcy, capping a dramatic period that saw the once high-flying startup navigate a failed initial public offering, forced government lockdowns, a blank-check merger, and a stubborn avoidance of return-to-office trends.

The company at its 2019 peak commanded a $47 billion valuation with the likes of SoftBank losing more than $14 billion on just this one investment.

The firm’s death spiral arguably started in 2019. In a matter of months, the company went from planning an IPO to firing thousands and procuring a multi-billion-dollar bailout.

WeWork was almost a scam from the beginning with its main business mission explained as to “elevate the world’s consciousness.”

The former CEO of WeWork Adam Neuman operated the business almost as a cult.

The company eventually went public in 2021 through a special purpose acquisition company, two years after its initially planned IPO. But that didn’t stop WeWork from hemorrhaging cash.

While WeWork reached a sweeping debt restructuring deal in early 2023, it quickly signaled desperation soon after.

High-interest rates are starting to knock out the low-quality business ideas that never should have gotten off the ground in the first place. 

These developments are a godsend for the tech economy that needs a complete flushing out of the bad ideas that were fueled by 0% interest rates.

Cheap money attracts larger-than-life ideas and personalities that can’t really back up the chutzpah.

Raising the bar for quality in tech has also caused the unintended consequence of raising the top tech companies or magnificent seven even higher up than before.

This trend can easily be seen in the EV sector where incumbent Tesla is putting their foot on the scruff of smaller EV company’s necks that simply can’t keep up with the higher material costs and headache of developing a global manufacturing presence amid deglobalization.

In simple terms, it is substantially harder to build an above-average tech company, or any tech company for that matter in 2023.

The former is an issue with the lofty competition that wields powerful balance sheets and the latter is an issue with draconian funding terms.

Waving goodbye to lemons like WeWork is only healthy for the tech sector in the long term and shortly we should see other junk-status companies be thrown by the wayside as well.

Cryptocurrency mogul Sam Bankman Fried’s fall from grace with a guilty verdict of fraud is another signal that the tech’s excesses are quickly normalizing.

We are in the middle of setting ourselves up for the new bull market in technology stocks which will be kicked into gear if interest rates sniff out the next recession.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-11-08 14:02:242023-11-08 18:56:01Setting Up For The Next Bull Market
april@madhedgefundtrader.com

Trade Alert - (BRKB) November 8, 2023 - TAKE PROFITS - SELL

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-11-08 13:13:232023-11-08 13:13:23Trade Alert - (BRKB) November 8, 2023 - TAKE PROFITS - SELL
april@madhedgefundtrader.com

November 8, 2023

Jacque's Post

 

(IT’S A GREEN LIGHT FOR THE MARKET ACCORDING TO THIS INDICATOR)

November 8, 2023

 

Hello everyone,

A reliable and rare market indicator is flashing green meaning we may well see good times on Wall Street for the next 12 months. 

This market indicator is called the Zweig Breadth Thrust.

It flashed a buy signal last Friday for only the 18th time since 1945.

When this happens the S&P 500 averages a 23.3% gain over the following 12 months and is up 100% of the time, history shows.

The gauge – a ratio developed by famous investor Marty Zweig – is used to determine market momentum, particularly the start of a potential move higher.  This signal is triggered when the ZBT rises from less than 0.4 to more than 0.615 within 10 days.

The thrust is calculated by:

Determining the ratio of advancing New York Stock Exchange listed names to the total number of rising and declining issues

Then find the 10-day exponential moving average of that ratio.

Put simply, it’s when you go from very oversold to very overbought in less than two weeks.

This by signal came as the S&P 500 wrapped up its biggest weekly gain of the year.  The index rallied 5.9% last week, marking its largest one-week surge since November 2022.  That move followed the Fed hinting it may be done raising rates.

The idea that the Fed may be done (we don’t know that for sure)

The idea that the economy is rebalancing normally (and not going straight into a recession)

Both are significant.

The technical signal mostly suggests that there is a lot more buying pressure coming in.  In other words, an end-of-year rally is still quite likely.

Some analysts believe the S&P 500 can end 2023 between 4,600 and 4,700.  This implies an upside of 5.5% to 7.8% from Friday’s close.  The index would then close out the year up 19.8% or 22.4%.

Remember that the Zweig Breadth Thrust is just one indicator.  The market could be impacted by numerous factors before the end of the year.

 

 

 

Have you heard of Digital Ocean?

It’s a Cloud Computing platform that is at an attractive entry point right now, according to Goldman Sachs.

Analysts have a price target of $33.00 which implies the stock could jump 38.4% over the next 12 months.

Analyst, Gabriela Borges, cited the stock’s significant underperformance as an opportunity for investors.  The stock is up 6% this year, while the Nasdaq Composite has gained 30%.

Borges believes the business is now approaching a cyclical trough.  Furthermore, she goes on to say that the structural improvements that DO has made to its mix and cost structure will become more obvious, driving better revenue growth, and continued (free cash flow) and margin expansion. 

According to Borges, the underperformance has likely been due to a cyclical normalization in cloud optimization spending.  She argues that this trend has been particularly acute in areas where DO has outsized exposure, such as video games, streaming, and web agencies.   Borges estimated that Digital Ocean’s organic revenue growth rate, excluding M&A and pricing, has slowed from 36% in the first quarter of 2022 to low single digits in the third quarter of this year.

The analyst points out there are positive catalysts ahead for the business, including Digital Ocean’s better-than-expected revenue and earnings for the third quarter and the company’s contributions from its newer initiatives.  These initiatives include DigitalOcean’s July acquisition of Paperspace, which should expand the company’s artificial intelligence and machine-learning capabilities, and its ongoing ramping of Cloudways, a cloud hosting and SaaS provider for small-to-medium-size businesses acquired last year.

A new CEO is yet to be announced, and until that happens, analysts do not see a material shift in DigitalOcean’s strategy.

Second Quarter 2023 Financial Highlights:

Revenue was $170 million, an increase of 27% year-over-year.  Annual Run-Rate Revenue (ARR) ended the quarter at $682 million, representing 25% year-over-year growth.  Gross profit of $102 million or 60% of revenue.

 

 

Digital Ocean (DOCN) Trade Idea

Stock Price $26.38.

January 19 (DOCN) $25/$27.50 vertical call spread at a cost of $1.30 (do not pay more than $1.40)

For those who want to be more aggressive, you can look at doing

January 19 (DOCN) $27.50/$30.00 vertical call spread at 0.88cents (do not pay more than 0.95cents)

McDonalds (MCD)

If you took advantage of the McDonald’s trade, I outlined two to three weeks ago, then don’t forget to look at taking profits. 

I gave the option of a 250/260 DEC call option spread or a 250/270 DEC call option spread.

MCD is sitting at $268.96 as I am writing this newsletter.

 

 

Cheers,

Jacquie

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-11-08 12:00:112023-11-08 14:15:26November 8, 2023
april@madhedgefundtrader.com

November 8, 2023

Diary, Newsletter, Summary

Global Market Comments
November 8, 2023
Fiat Lux

(I HAVE A NEW OPENING FOR THE MAD HEDGE FUND TRADER CONCIERGE SERVICE),
(TESTIMONIAL),
(RIGHT SIZING YOUR TRADING)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-11-08 09:08:172023-11-08 10:49:19November 8, 2023
april@madhedgefundtrader.com

Trade Alert - (MSFT) November 7, 2023 - BUY

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-11-07 13:06:342023-11-07 13:20:29Trade Alert - (MSFT) November 7, 2023 - BUY
april@madhedgefundtrader.com

November 7, 2023

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
November 7, 2023
Fiat Lux

Featured Trade:

(OUTSMARTING OPIOIDS)

(VRTX), (LLY), (NVO), (BIIB)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-11-07 12:02:402023-11-07 12:07:08November 7, 2023
april@madhedgefundtrader.com

Outsmarting Opioids

Biotech Letter

Amid the stark realities of America's opioid crisis, with a staggering 80,000 annual fatalities due to overdose, the pharmaceutical industry is on the brink of a significant shift.

Vertex Pharmaceuticals (VRTX) stands out with its investigational drug VX-548, which promises a novel approach to pain management without the addiction risks of opioids. As the year winds down, this biotechnology company is poised to reveal findings from four clinical trials that could catapult VX-548 into the market spotlight.

Needless to say, the stakes couldn't be higher for Vertex.

The commercial success of VX-548, particularly in the chronic pain market, could mark a significant turning point. While generic opioids are cost-effective for short-term use, their potential for addiction and other risks make a non-addictive alternative like VX-548 an attractive proposition for insurers and patients alike.

Drawing parallels to the recent rise of GLP-1 obesity drugs by Eli Lilly (LLY) and Novo Nordisk (NVO), VX-548 could potentially mirror their impact.

Successful trials could see VX-548 generating annual revenues of $5.1 billion by 2030 — a substantial addition to Vertex’s current cystic fibrosis portfolio, which pulls in just shy of $10 billion.

Yet, it's essential to temper enthusiasm with a dose of reality. After all, the biotech sector is no stranger to the pitfalls of high expectations.

Past failures in the nonopioid pain sector underscore the importance of cautious optimism. Nerve growth factor inhibitors, once hailed as a breakthrough, faltered due to safety concerns, highlighting the unpredictable nature of drug development.

VX-548 aims to circumvent these issues with its unique mechanism of action that targets pain signaling at the peripheral nervous system—potentially a significant advantage over central nervous system-targeting opioids.

So, investors must weigh the risk-reward ratio of betting on Vertex ahead of these results.

This treatment’s success in acute pain management could result in a significant uptick in Vertex's stock value. Analyst projections suggest a potential increase of $58 per share if VX-548 matches opioid efficacy, with an $88 increase if it surpasses it. Should the chronic pain trials yield positive results, the stock could climb an additional $119 per share.

However, like I said, it's crucial to approach these numbers with caution. The market's response to trial outcomes can be unpredictable, and the memory of recent high-profile disappointments, such as Biogen's (BIIB) Aduhelm, still lingers.

In light of this, the downside should not be understated — a failed trial could see Vertex's stock take a substantial hit, potentially up to 20%.

Nevertheless, the financial health of Vertex remains strong even sans this pain management candidate. In fact, its top-selling TRIKAFTA/KAFTRIO patents are secured through 2037, accounting for a dominant 89.9% of sales.

This foundation provides a buffer against the inherent risks that come with drug development. With operating margins at a solid 45.6% and a GAAP EPS increase of 30.8% quarter over quarter, Vertex displays a financial resilience that may be reassuring to interested investors.

Taking everything into consideration, investors stand at a crossroads, with the potential of VX-548 offering both promise and uncertainty. The decision to invest now hinges on more than just the outcomes of the trials; it requires strategic consideration of the broader market, potential competitors, and the overarching trends in pain management.

As Wall Street watches with a trained eye, the early indications from Vertex’s trials suggest that VX-548 has a fighting chance to succeed where others have faltered.

If its subsequent tests affirm its potential, VX-548 could not only transform the company’s financial landscape but also mark a significant advancement in the fight against the opioid epidemic — a win for both public health and discerning investors. I suggest you buy the dip.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-11-07 12:00:582023-11-07 12:05:11Outsmarting Opioids
april@madhedgefundtrader.com

Trade Alert - (NVDA) November 7, 2023 - TAKE PROFITS - SELL

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-11-07 11:55:582023-11-07 11:58:44Trade Alert - (NVDA) November 7, 2023 - TAKE PROFITS - SELL
april@madhedgefundtrader.com

November 7, 2023

Diary, Newsletter, Summary

Global Market Comments
November 7, 2023
Fiat Lux

MY BEN BERNANKE INTERVIEW

Featured Trade:
(COFFEE WITH BEN BERNANKE)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-11-07 09:04:432023-11-07 11:20:28November 7, 2023
april@madhedgefundtrader.com

Coffee With Ben Bernanke

Diary, Newsletter

During 2008-2009, when the financial markets completely fell to pieces, and credit froze up, I thought, “Great, I am going to have to spend the rest of my life reliving my grandparents’ Great Depression.

One of the great policy minds of our generation, Ben Bernanke, single-handedly made sure that didn’t happen. He knew what he needed to do, was creative, and took bold action, even though he was well aware that it was diametrically opposed to his own political party’s principles.

An uproar ensued.

Now a fellow at the famed think tank, the Brooking Institution in Washington DC, Ben passed through town recently to promote his latest book out in 2022 entitled “21st Century Monetary Policy: The Federal Reserve from the Great Inflation to COVID-19.”

For eight years I watched Bernanke speak at press conferences in the most careful, restrained, cautious manner possible. After all, as the governor of America’s central bank, a mere slip of the tongue could cause panic and financial destruction. Each one was like attending a graduate class in economics. I learned from all of them.

Today, he is a completely different man. Voluble, opinionated, and even sarcastic, he let loose with one blockbuster revelation after another. It was like the dam broke, and he was making up for lost time.

Today, Bernanke counts time in terms of Federal Open Market Committee meetings (the FOMC).

He describes the week that Lehman Brothers went bankrupt as the worst panic in American history. He tried to sell it to Bank of America or Barclays Bank. But when they discovered a whopping great $70 billion hole in the balance sheet, the wheels fell off.

The bailout of insurance giant AIG was an easier sell to President George W. Bush. Although it was $85 billion in the hole, it had $1 trillion in assets, which could eventually be liquidated. They were, creating immense profits for the government.

Ben describes the TARP bank rescue package as the least popular, most successful government program in history. It was the first time the federal government took equity ownership in private banks, some 5% of the top 20.

Totally against the president’s own ideology, and voted down by his own Republican Party, it ended up generating a profit of almost $100 billion.

Oh, and it saved the global financial system too.

The key to the economic recovery was for the Fed to aggressively cut interest rates, while Europe was raising theirs. US stock markets certainly believed in it, nearly tripling off a March 2009 bottom, while the continent stagnated for six more years.

No money was ever printed during quantitative easing, contrary to popular belief. The Fed simply bought $8 trillion in bonds from the Treasury and will run them to maturity.

It’s as if they never existed. Money simply went out of one pocket into another, and the broad monetary measures were left untouched by human hands.

Ben believed he could pursue such an aggressive stance because inflationary concerns back then were “complete nonsense.”

The former Yale professor concedes that the Fed underestimated the impact of the crash. The GDP growth rate since then has been lower than he anticipated, but unemployment fell faster than thought possible, from 10.2% to 3.8% as of today.

The Fed also kept the economy from falling into the kind of liquidity trap that has mired Japan for 33 years. When prices fall, consumers hold back, knowing they can get a better deal, sapping the life out of the economy.

In the meantime, lenders are punished, as the collateral backing their debt declines as well. This is why almost all central banks are deliberately targeting a 2% inflation rate today, including ours.

Ben noted that the technologically uneducated have suffered more in this recovery than in past ones, as the rate of innovation has been so frenetic, and is accelerating thanks to AI.

This has particularly disadvantaged blue-collar workers the most, where job gains have been the weakest. Hence the recent United Auto Workers strike.

Bernanke was the smartest kid in rural Dillon, South Carolina, who, through a series of improbable accidents, and intervention by a local black civil rights leader, ended up at Harvard.

He built his career on studying the Great Depression, then the closest thing to paleontology economics had to offer, a field focused so distantly on the past that it was thought to be irrelevant.

Bernanke took over the Fed in 2006 when Greenspan was considered a rock star, inhaling his libertarian, free-market, Ayn Rand-inspired philosophy in great giant gulps.

Within a year, the economy had suddenly transported itself back to the Jurassic Age, and the landscape was suddenly overrun with T-Rex’s and Brontesauri.

He tried to stop the panic in 150 different ways, 125 of which were terrible ideas, the remaining 25 saving us from the Great Depression II.

The Fed governor is naturally a very shy and withdrawing person and would have been quite happy limiting his political career to the Princeton, New Jersey school board.

To rebuild confidence, he took his campaign to the masses, attending town hall meetings and pressing the flesh like a campaigning first-term congressman.

The price tag for Ben’s success has been large, with the Fed balance sheet exploding from $800 million to $9 trillion. The true cost of the financial crisis won’t be known for a decade or more.

Ben thinks that the biggest risk is that we grow complacent, having pulled back from the brink, and let desperately needed reforms of the financial system and the rebuilding of Fannie Mae and Freddie Mac slide.

Ben Bernanke’s legacy will be defined by how well his successors do their jobs. That’s when we find out who Ben Bernanke really was.

Unwind the massive Fed balance sheet too soon, and we go back into a real depression. Too late, and hyperinflation hits. They call this “Threading the needle.”

Yikes!

Today, Bernanke sees absolutely no signs of a coming recession whatsoever. Housing has yet to seriously join the party, but will.

This is big if you are a daily player in the stock market, such as myself. He is rightfully proud of the work he did restoring the economy.

Bernanke also voiced complete confidence in his hand-picked successor, and my friend, former Berkeley professor Janet Yellen.

Ben finished our meeting with a sigh of relief, saying he was “Glad he doesn’t have to do this anymore.”

I’m happy too that we no longer need a Ben Bernanke to save our bacon. There might not be another available.

 

https://www.madhedgefundtrader.com/wp-content/uploads/2018/05/Ben-Bernanke-story-3.jpg 313 250 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2023-11-07 09:02:362023-11-07 12:04:54Coffee With Ben Bernanke
Page 12 of 15«‹1011121314›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top